Isolation of 6,6’-Bieckol from Grateloupia elliptica and its Antioxidative and Anti-Cholinesterase Activity

키워드

참고문헌 (28)

1. Artan M, "Anti-HIV-1 activity of phloroglucinol derivative, 6,6′-bieckol, from Ecklonia cava", Bioorgan Med Chem, 16(17), pp.7921~7926 (2008)
2. Blois MS, "A note on free radical formation in biologically occurring quinones", Biochim Biophys Acta, 18, pp.165~ (1955)
3. Brossi A, "Bioactive alkaloids. 4. results of recent investigations with colchicine and physostigmine", J Med Chem, 33, pp.2311~2319 (1990)
4. Choi BW, "Multifunctional activity of polyphenolic compounds associated with a potential for alzheimer’s disease therapy from Ecklonia cava", Phytother Res, 29, pp.549~553 (2015)
5. Courtney C, "AD2000collaborative group. Long-term donepezil treatment in 565 patients with Alzheimer’s disease (AD2000):randomised double-blind trial", Lancet, 363(9427), pp.2105~2115 (2004)
6. Cummings JL, "Cholinesterase inhibitors: a new class of psychotropic compounds", Am J Psychiatry, 157, pp.4~15 (2000)
7. Drachman DA, "Human memory and the cholinergic system. A relationship to ageing?", Arch Neurol, 30, pp.113~121 (1974)
8. Ellmans GL, "A new and rapid colorimetric determination of acetylcholinesterase activity", Biochem Pharmacol, 7, pp.88~95 (1961)
9. Giacobini E, "Cholinesterases and cholinesterase inhibitors", pp.280~ (2000), Martin Dunitz Ltd
10. Greig NH, "Phenserine and ring C hetero-analogs: drug candidates for the treatment of Alzheimer's disease", Med Res Rev, 15(1), pp.3~31 (1995)
11. Greig NH, "A new therapeutic target in Alzheimer’s disease treatment:attention to butyrylcholinesterase", Curr Med Res Opin, 17(2), pp.1~6 (2001)
12. Greig NH, "Its Function and Inhibition", pp.69~90 (2003), Martin Dunitz Ltd
13. Greig NH, "Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent", P Natl Acad Sci, 102, pp.17213~17218 (2005)
14. Greig NH, "An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer’s disease", Curr Alzherimer Res, 2, pp.281~291 (2005)
15. Hirase S, "Component sugars of the polysaccharide of the red seaweed Grateloupia elliptica", B Chem Soc Jpn, 40(6), pp.1445~1448 (1967)
16. Kim KY, "Potent alpha-glucosidase inhibitors purified from the red alga Grateloupia elliptica", Phytochemistry, 69, pp.2820~2825 (2008)
17. Lahiri DK, "Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents", Curr Pharm Design, 10, pp.3111~3119 (2004)
18. Lee MS, "Isolation and identification of phlorotannins from Ecklonia stolonifera with antioxidant and hepatoprotective properties in Tacrine-Treated HepG2 cells", J Agric Food Chem, 60(21), pp.5340~5349 (2012)
19. Liu JY, "Checklist of biota of Chinese seas" (2008), China Science Press
20. Liu JS, "The structures of huperzine A and B, two new alkaloids exhibiting marked anticholinesterase activity", Can J Chemistry, 64(4), pp.837~839 (1986)
21. Lopez OL, "Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition", J Am Geriatr Soc, 53, pp.83~87 (2005)
22. Sambamurti K, "Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer’s disease", Neuromol Med, 1, pp.1~31 (2002)
23. Sambamurti K, "A partial failure of membrane protein turnover may cause Alzheimer’s disease: a new hypothesis", Curr Alzherimer Res, 3, pp.81~90 (2006)
24. Selkoe DJ, "Defining molecular targets to prevent Alzheimer disease", Arch Neurol, 62(2), pp.192~195 (2005)
25. Vassar R, "Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE", Science, 286(5440), pp.735~741 (1999)
26. Vassar R, "Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE", Science, 286(5440), pp.735~741 (1999)
27. Walker LC, "Alzheimer therapeutics-what after the cholinesterase inhibitors?", Age and Ageing, 35(4), pp.332~335 (2006)
28. Yu QS, "Synthesis of novel phenserine-based selective inhibitors of butyrylcholinesterase for Alzheimer’s disease", J Med Chem, 42(10), pp.1855~1861 (1999)

관련 논문AI추천